Etigilimab with Nivolumab in Locally Advanced or Metastatic Solid Tumors
What is the Purpose of this Study?
- Get the study drugs, etigilimab and nivolumab, by I.V. once every 2 weeks
- Give blood and urine samples
- Have regular CT or MRI scans
Who Can Participate in this Study?
Adults with cancer that:
- Consists of solid tumors
- Is recurrent, locally advanced, or metastatic
What is Involved?
We are doing this study to see if the study drugs, etigilimab and nivolumab, are safe and effective for fighting your cancer.